NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,410.46 +203.33 (+1.12%) CRUDE OIL
79.22 +0.27 (+0.34%) GOLD FUTURES
2,310.50 +0.90 (+0.04%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,581.48 +1,789.84 (+3.91%)
Envoy Medical, Inc. (COCH)
After hours:
| Previous close | 4.4300 |
| Open | 4.6700 |
| Bid | 4.5500 x 100 |
| Ask | 5.0000 x 100 |
| Day's range | 4.6700 - 4.9900 |
| 52-week range | 0.7470 - 11.7200 |
| Volume | |
| Avg. volume | 455,842 |
| Market cap | 95.06M |
| Beta (5Y monthly) | 2.66 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.3800 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.00 |
GlobeNewswireEnvoy Medical to Present at the Planet MicroCap Showcase: Vegas 2024
WHITE BEAR LAKE, Minnesota, April 24, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that David R. Wells, Chief Financial Officer, will present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024. The conference is being held on April 30 – May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV. Presentation Date: May 1, 2024 Time: 8:30am Pacific Time
- GlobeNewswire
Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024
WHITE BEAR LAKE, Minnesota , April 03, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that Brent Lucas, Chief Executive Officer, and David R. Wells, Chief Financial Officer, will present a corporate overview at the LD Micro Invitational XIV 2024. The conference is being held on April 8 - 9, 2024 at the Sofitel Hotel in New York City. Presentation Date: Tuesday, Apri
- GlobeNewswire
Envoy Medical Reports Fourth Quarter and Full Year 2023 Financial Results
Company Provides Corporate Update that Include Updates on its Investigational Fully Implanted Acclaim® Cochlear Implant Meeting its Early Feasibility Study Milestones Recent bipartisan Congressional bill, the Hearing Device Coverage Clarification Act, seeks to open a pathway to insurance coverage for the Company's Esteem® Fully Implanted Active Middle Ear Implant WHITE BEAR LAKE, Minn., April 02, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hear
